Assessing genetic-based therapies for AIDS using the simian immunodeficiency virus

J Med Primatol. 1995 May;24(3):141-4. doi: 10.1111/j.1600-0684.1995.tb00159.x.

Abstract

A plasmid encoding the full-length infectious molecular proviral clone of SIVmac239 was generated. Virus derived from cells transfected with this clone replicated to high levels and was cytopathic for some transformed human CD4+ cell lines and primary rhesus macaque peripheral blood mononuclear cells. Since replication of SIV requires the functional expression of the viral encoded rev protein, transient co-transfection studies were initiated with the infectious proviral clone and a well-characterized trans-dominant negative HIV-1 rev mutant.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD4-Positive T-Lymphocytes / immunology
  • Cell Line, Transformed
  • Cloning, Molecular
  • Gene Transfer Techniques
  • Genes, rev*
  • Leukocytes, Mononuclear / immunology
  • Macaca mulatta
  • Mutation
  • Plasmids
  • Proviruses / genetics*
  • Simian Immunodeficiency Virus / genetics*
  • Simian Immunodeficiency Virus / growth & development*
  • Simian Immunodeficiency Virus / isolation & purification
  • Time Factors
  • Transfection*
  • Virus Replication